Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

Ann Hematol. 2003 Oct;82(10):654-9. doi: 10.1007/s00277-003-0685-2. Epub 2003 Jul 4.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Combined Modality Therapy
  • Dexamethasone / administration & dosage
  • Disease-Free Survival
  • Doxorubicin / administration & dosage
  • Drug Administration Schedule
  • Humans
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Prospective Studies
  • Stem Cell Transplantation
  • Thalidomide / administration & dosage*

Substances

  • Thalidomide
  • Dexamethasone
  • Doxorubicin